Supporting data for: Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesia
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'Data on stock and distribution volumes over time by molecule, doseform, INN status, price bracket, outlet type (distributor, health facility, pharmacy) for five cardiovascular medicines (amlodipine, captopril, furosemide, glibenclamide, simvastatin) in Malang district, East Java, at the start of the COVID-19 pandemic, JanUARY - October 2020. Data support the submitted manuscript:  Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesi' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["pharmaceutical, medicine, COVID-19, cardiovascular, supply chain"]} <|eot_id|>
 Here is the Description of a dataset. Description:'Data on stock and distribution volumes over time by molecule, doseform, INN status, price bracket, outlet type (distributor, health facility, pharmacy) for five cardiovascular medicines (amlodipine, captopril, furosemide, glibenclamide, simvastatin) in Malang district, East Java, at the start of the COVID-19 pandemic, JanUARY - October 2020. Data support the submitted manuscript:  Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesi' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
Data on stock and distribution volumes over time by molecule, doseform, INN status, price bracket, outlet type (distributor, health facility, pharmacy) for five cardiovascular medicines (amlodipine, captopril, furosemide, glibenclamide, simvastatin) in Malang district, East Java, at the start of the COVID-19 pandemic, JanUARY - October 2020. Data support the submitted manuscript:  Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesi
pharmaceutical, medicine, COVID-19, cardiovascular, supply chain